Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Coeur Mining
CDE
$19B
| $14.9M | ﹤0.01% |
4,561,874
+408,122
| +10% | +$1.11M |
|
1777
Nabors Industries
NBR
$1.35B
| $14.8M | ﹤0.01% |
181,613
+13,980
| +8% | +$1.35M |
|
|
HCP
1778
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $14.8M | ﹤0.01% |
626,926
+63,879
| +11% | +$1.38M |
|
1779
Ironwood Pharmaceuticals
IRWD
$674M
| $14.7M | ﹤0.01% |
1,288,653
+57,859
| +5% | +$572K |
|
1780
Acco Brands
ACCO
$399M
| $14.7M | ﹤0.01% |
2,422,023
+68,416
| +3% | +$363K |
|
1781
TriCo Bancshares
TCBK
$1.86B
| $14.7M | ﹤0.01% |
342,419
+14,200
| +4% | +$509K |
|
|
ACLX
1782
DELISTED
Arcellx
ACLX
| $14.7M | ﹤0.01% |
264,178
+3,722
| +1% | +$168K |
|
|
DISH
1783
DELISTED
DISH Network Corp.
DISH
| $14.7M | ﹤0.01% |
2,540,412
+226,765
| +10% | +$1.02M |
|
|
CSR
1784
Centerspace
CSR
$939M
| $14.6M | ﹤0.01% |
251,117
+3,272
| +1% | +$179K |
|
1785
Protolabs
PRLB
$2.21B
| $14.6M | ﹤0.01% |
375,112
-10,084
| -3% | -$327K |
|
1786
Vericel Corp
VCEL
$2.28B
| $14.6M | ﹤0.01% |
410,390
+8,291
| +2% | +$289K |
|
|
1787
Novartis
NVS
$288B
| $14.6M | ﹤0.01% |
146,409
-4,237,440
| -97% | -$409M |
|
1788
AerCap
AER
$23.5B
| $14.5M | ﹤0.01% |
195,760
+647
| +0.3% | +$42.7K |
|
1789
Upwork
UPWK
$1.08B
| $14.5M | ﹤0.01% |
977,073
+20,703
| +2% | +$267K |
|
1790
Conduent
CNDT
$252M
| $14.5M | ﹤0.01% |
3,979,612
+165,969
| +4% | +$525K |
|
1791
Bumble
BMBL
$359M
| $14.5M | ﹤0.01% |
984,055
+28,209
| +3% | +$400K |
|
1792
OceanFirst Financial
OCFC
$1.88B
| $14.5M | ﹤0.01% |
834,391
+139,047
| +20% | +$2.03M |
|
1793
Goosehead Insurance
GSHD
$2.39B
| $14.4M | ﹤0.01% |
190,550
+7,502
| +4% | +$542K |
|
1794
Viking Therapeutics
VKTX
$3.84B
| $14.4M | ﹤0.01% |
775,699
+10,379
| +1% | +$136K |
|
1795
Reynolds Consumer Products
REYN
$5.55B
| $14.4M | ﹤0.01% |
536,320
+50,425
| +10% | +$1.32M |
|
1796
Banc of California
BANC
$3.11B
| $14.4M | ﹤0.01% |
1,071,139
+633,132
| +145% | +$7.82M |
|
1797
MaxLinear
MXL
$6.95B
| $14.4M | ﹤0.01% |
605,061
-27,190
| -4% | -$532K |
|
1798
Standard Motor Products
SMP
$870M
| $14.4M | ﹤0.01% |
361,255
+13,101
| +4% | +$467K |
|
|
OPI
1799
DELISTED
Office Properties Income Trust
OPI
| $14.4M | ﹤0.01% |
1,964,664
+315,094
| +19% | +$1.68M |
|
|
SAFE
1800
Safehold
SAFE
$1.1B
| $14.4M | ﹤0.01% |
613,450
+40,556
| +7% | +$764K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.